Efficacy of Repaglinide in Subjects With Type 2 Diabetes
Clinical trial NCT01698931 · COMPLETED
Trial details
- NCT number
- NCT01698931
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2002-04-26
- Primary completion
- 2003-03-06
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.